www.fdanews.com/articles/81443-trillium-acquires-arthron-ltd
TRILLIUM ACQUIRES ARTHRON LTD.
October 6, 2005
Trillium Therapeutics Inc. (TTI), a Canadian biopharmaceutical company, today announced that it has acquired all assets belonging to Arthron Ltd. Pty. (Arthron), a subsidiary of Prima Biomed Ltd. (Prima). Prima, a publicly traded Australian biotechnology company, develops technologies in the fields of immunology and cancer immunotherapy originating from the Austin Research Institute, in Melbourne, Australia.
Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/October2005/06/c7992.html)